Alfredo Addeo
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 239 publications
Is There Still Room for Monotherapy in EGFR-Mutated Non-Small Cell Lung Cancer?
Journal: JAMA
Published: August 10, 2026
PD-(L)1 containing rechallenge strategies in patients with advanced NSCLC previously treated with immunotherapy: A systematic review and meta-analysis across resistance phenotypes.
Journal: Cancer treatment reviews
Published: March 06, 2026
Corrigendum to "Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)" [Eur J Cancer 2025 Nov 29:232:116138].
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 23, 2026
Involving Patient Partners: Platforms and Strategies in French-Speaking Switzerland
Journal: Revue medicale suisse
Published: December 11, 2025
Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.
Journal: Oncology
Published: November 27, 2025
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Mutant Non-Small Cell Lung Cancer across Treatment Lines: Evidence from the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 13, 2025
Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far?
Journal: Cancer treatment reviews
Published: October 26, 2025
Real-world outcomes of stage III NSCLCs managed by surgery or definitive radiation therapy in the era of immunotherapy.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 29, 2025
Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.
Journal: JTO clinical and research reports
Published: September 09, 2025
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 25, 2025
Last Updated: 09/26/2026